JT

Jonathan Tobin

Investor-in-residence at Cancer Research Horizons

Jonathan Tobin is currently a Partner at Brandon Capital where Jonathan focuses on leading investments in biotech companies globally. Jonathan also holds various Non-Executive Director positions in several pharmaceutical and biotech companies. In addition, Jonathan is a Member of the Investment Advisory Committee at KHAN Technology Transfer Fund I. Prior to their current roles, Jonathan served as the Managing Director at Arix Bioscience plc, specializing in biotech investments. Jonathan Tobin graduated with a MA in Biological Science from the University of Oxford, an MBA in Business Administration and Management from Imperial College London, and a PhD in Molecular Medicine from UCL.

Links

Previous companies

Genomics England logo

Timeline

  • Investor-in-residence

    September, 2023 - present